Literature DB >> 1330889

DNA rearrangements in the alpha 5(IV) collagen gene (COL4A5) of individuals with Alport syndrome: further refinement using pulsed-field gel electrophoresis.

D Vetrie1, E Boye, F Flinter, M Bobrow, A Harris.   

Abstract

Alport syndrome (AS), an X-linked kidney disorder, has been shown to be caused by mutations in the gene for the alpha 5-chain of type IV collagen (COL4A5), which maps to Xq22. On the basis of the results of conventional Southern blot analysis of AS patient DNAs, we employed pulsed-field gel electrophoresis to characterize further three gene rearrangements at the 3'-end of alpha 5(IV). We were able to construct long-range restriction maps for all three of these patients and deduce the extent and nature of each rearrangement. One of these mutations is a 450-kb simple deletion that includes 12 kb of the alpha 5(IV) gene. A second mutation has been shown to be a direct duplication of 35 kb of alpha 5(IV) genomic DNA, and a third mutation involves a complex insertion/deletion event resulting in an overall loss of 25 kb.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1330889     DOI: 10.1016/s0888-7543(05)80161-2

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  4 in total

1.  Alport syndrome caused by inversion of a 21 Mb fragment of the long arm of the X-chromosome comprising exon 9 through 51 of the COL4A5 gene.

Authors:  Jens Michael Hertz; Ulf Persson; Inger Juncker; Mårten Segelmark
Journal:  Hum Genet       Date:  2005-10-28       Impact factor: 4.132

Review 2.  Alport's syndrome.

Authors:  F Flinter
Journal:  J Med Genet       Date:  1997-04       Impact factor: 6.318

3.  Evidence for disease penetrance relating to CNV size: Pelizaeus-Merzbacher disease and manifesting carriers with a familial 11 Mb duplication at Xq22.

Authors:  C M B Carvalho; M Bartnik; D Pehlivan; P Fang; J Shen; J R Lupski
Journal:  Clin Genet       Date:  2011-06-20       Impact factor: 4.438

4.  Alport syndrome and leiomyomatosis: the first deletion extending beyond COL4A6 intron 2.

Authors:  Vera Uliana; Elena Marcocci; Mafalda Mucciolo; Ilaria Meloni; Claudia Izzi; Carlo Manno; Mirella Bruttini; Francesca Mari; Francesco Scolari; Alessandra Renieri; Leonardo Salviati
Journal:  Pediatr Nephrol       Date:  2010-12-14       Impact factor: 3.714

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.